Changlai S P, Kao C H, Wang S J, Lin W Y, Lan J L
Department of Nuclear Medicine, Chung-Shan Medical College Hospital, Taiwan, Republic of China.
Clin Nucl Med. 1995 Jul;20(7):626-9. doi: 10.1097/00003072-199507000-00014.
This study evaluated the effects of corticosteroid inhalation on the deposition pattern of Tc-99m HSA radioaerosols in 24 patients with asthma. The homogeneous degree of depositing radioaerosol was quantitatively evaluated using a modified standard score system over both lungs. The baseline scores were calculated before inhalation therapy of 0.05 mg beclomethasone dipropionate four times daily for 1 week. The studies were then repeated after treatment to evaluate the effects of inhalation therapy. After treatment, the scores decreased in 16 of 24 cases (67%), which means that the degree of the bronchial obstruction decreased. The statistical results revealed significant differences in the total homogeneity score (P < 0.001) before and after therapy. Thus, a 1-week course of beclomethasone dipropionate inhalation therapy improves the bronchial obstruction in asthma patients as shown by the quantitative homogeneity score system of the Tc-99m HSA radioaerosol inhalation lung scintigraphy.
本研究评估了皮质类固醇吸入对24例哮喘患者中锝-99m人血清白蛋白放射性气溶胶沉积模式的影响。使用改良的标准评分系统对双肺放射性气溶胶沉积的均匀程度进行定量评估。在每日4次吸入0.05毫克二丙酸倍氯米松治疗1周前计算基线评分。然后在治疗后重复这些研究以评估吸入治疗的效果。治疗后,24例中的16例(67%)评分降低,这意味着支气管阻塞程度减轻。统计结果显示治疗前后总均匀性评分存在显著差异(P < 0.001)。因此,如锝-99m人血清白蛋白放射性气溶胶吸入肺闪烁显像的定量均匀性评分系统所示,为期1周的二丙酸倍氯米松吸入治疗疗程可改善哮喘患者的支气管阻塞。